Search Results - "Caubet, Magalie"
-
1
Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants
Published in npj vaccines (21-05-2021)“…Differences in innate immune ‘imprinting’ between vaccine adjuvants may mediate dissimilar effects on the quantity/quality of persisting adaptive responses. We…”
Get full text
Journal Article -
2
Utility of urinary cytokine levels as predictors of the immunogenicity and reactogenicity of AS01-adjuvanted hepatitis B vaccine in healthy adults
Published in Vaccine (26-04-2022)“…Plasma cytokines are useful indicators of the inflammatory response to vaccination, and can serve as potential biomarkers of the systemic reactogenicity and…”
Get full text
Journal Article -
3
Safety and Immunogenicity of an Adjuvanted Clostridioides difficile Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 Study
Published in The Journal of infectious diseases (24-10-2024)“…This study investigated the safety, reactogenicity, and immunogenicity in healthy subjects of a Clostridioides difficile vaccine candidate with/without…”
Get full text
Journal Article -
4
Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans
Published in Vaccine (28-03-2019)“…Highlights•Reactogenicity and inflammatory markers evaluated after HBsAg-adjuvanted vaccines. •Significant associations between systemic symptoms and IL-6 and…”
Get full text
Journal Article -
5
Phase I, randomized, observer-blind, placebo-controlled studies to evaluate the safety, reactogenicity and immunogenicity of an investigational non-typeable Haemophilus influenzae (NTHi) protein vaccine in adults
Published in Vaccine (08-06-2016)“…Abstract Background Non-typeable Haemophilus influenzae (NTHi) is a major cause of various respiratory diseases. The development of an effective vaccine…”
Get full text
Journal Article -
6
Erratum to “Phase I, randomized, observer-blind, placebo-controlled studies to evaluate the safety, reactogenicity and immunogenicity of an investigational non-typeable Haemophilus influenzae (NTHi) protein vaccine in adults” [Vaccine 34 (2016) 3156–3163]
Published in Vaccine (09-10-2017)“…The Publisher regrets that Panel C was omitted from Fig. 3 in the published version of this article. Fig. 3 is reproduced below in its entirety:…”
Get full text
Journal Article -
7
Randomized Controlled Study of the Safety and Immunogenicity of Pneumococcal Vaccine Formulations Containing PhtD and Detoxified Pneumolysin with Alum or Adjuvant System AS02(V) in Elderly Adults
Published in Clinical and vaccine immunology (2014)“…Six vaccine formulations containing AS02(V) or alum (aluminum phosphate [AlPO4]) adjuvant with pneumococcal proteins, pneumococcal histidine triad D (PhtD),…”
Get full text
Journal Article -
8
A Randomized, Controlled Trial to Assess the Immunogenicity and Safety of a Heptavalent Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis, Hib and Meningococcal Serogroup C Combination Vaccine Administered at 2, 3, 4 and 12-18 Months of Age
Published in The Pediatric infectious disease journal (01-07-2013)“…Combination vaccines offer protection against multiple diseases with fewer injections. This study evaluated the immunogenicity and safety of an investigational…”
Get full text
Journal Article -
9
A Combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C Tetanus Toxoid Conjugate Vaccine Is Immunogenic and Well-tolerated When Coadministered With Diphtheria, Tetanus, Acellular Pertussis Hepatitis B―inactivated Poliovirus at 3, 5 and 11 Months of Age: Results of an Open, Randomized, Controlled Study
Published in The Pediatric infectious disease journal (01-05-2013)“…This study evaluated the immunogenicity, reactogenicity and safety of the combined Haemophilus influenzae type B Neisseria meningitidis serogroup C tetanus…”
Get full text
Journal Article -
10
Randomized Controlled Study of the Safety and Immunogenicity of Pneumococcal Vaccine Formulations Containing PhtD and Detoxified Pneumolysin with Alum or Adjuvant System AS02 V in Elderly Adults
Published in Clinical and vaccine immunology (01-05-2014)“…ABSTRACT Six vaccine formulations containing AS02 V or alum (aluminum phosphate [AlPO 4 ]) adjuvant with pneumococcal proteins, pneumococcal histidine triad D…”
Get full text
Journal Article -
11
Phase II Study of a Three-dose Primary Vaccination Course of DTPa-IPV/Hib-MenC-TT Followed by a 12-month Hib-MenC-TT Booster in Healthy Infants
Published in The Pediatric infectious disease journal (01-06-2013)“…To test for immunologic noninferiority of antibody responses to Hib and MenC using a 6-in-1 combination vaccine (DTPa-IPV/Hib-MenC-TT) compared with…”
Get full text
Journal Article -
12
IMMEDIATE AND LONGER TERM IMMUNOGENICITY OF A SINGLE DOSE OF THE COMBINED HAEMOPHILUS INFLUENZAE TYPE B-NEISSERIA MENINGITIDIS SEROGROUP C-TETANUS TOXOID CONJUGATE VACCINE IN PRIMED TODDLERS 12 TO 18 MONTHS OF AGE
Published in The Pediatric infectious disease journal (01-04-2011)“…Hib-primed but MenC-naive toddlers (N = 433) were randomized to receive 1 dose of Hib-MenC-TT or separate Hib-TT and MenC-CRM197 vaccines. One month later,…”
Get full text
Journal Article -
13
Persistence clinical studies: Can you believe what you see?
Published in Human vaccines & immunotherapeutics (01-06-2013)“…Long-term immunity, evaluated by the persistence of antibody titers, is important to assess duration of protection induced by vaccination. This paper aims at…”
Get full text
Journal Article -
14
Randomized controlled study of the safety and immunogenicity of pneumococcal vaccine formulations containing PhtD and detoxified pneumolysin with alum or adjuvant system AS02V in elderly adults
Published in Clinical and vaccine immunology (01-05-2014)“…Six vaccine formulations containing AS02V or alum (aluminum phosphate [AlPO4]) adjuvant with pneumococcal proteins, pneumococcal histidine triad D (PhtD),…”
Get full text
Journal Article -
15
Five-year Antibody Persistence and Safety Following a Booster Dose of Combined Haemophilus influenzae Type b–Neisseria meningitidis Serogroup C–Tetanus Toxoid Conjugate Vaccine
Published in The Pediatric infectious disease journal (01-10-2012)“…BACKGROUND:Booster vaccination with the combined Haemophilus influenza type b-Neisseria meningitides serogroup C-tetanus toxoid vaccine (Hib-MenC-TT) has been…”
Get full text
Journal Article